FDA recall D-1049-2017

Hospira a Pfizer Company · Class II · drug

Product

Neut Sodium Bicarbonate 4% (2.4 mEq) Additive Solution 5 mL , a.) Single-dose vial (NDC 0409-6609-02), b.) 25 vial carton (NDC 0409-6609-25), Rx Only, Mfd by Hospira, INC, Lake Forest, IL 60045 USA

Reason for recall

Lack of Sterility Assurance

Distribution

U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

Key facts

Status
Terminated
Initiation date
2017-06-15
Report date
2017-08-09
Termination date
2020-07-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
Rocky Mount, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1049-2017